These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 843876)
1. Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"? Lawson DH; Henry DA Br Med J; 1977 Mar; 1(6062):691-2. PubMed ID: 843876 [No Abstract] [Full Text] [Related]
3. Monitoring of drugs after marketing. J R Coll Gen Pract; 1983 Jul; 33(252):438-41. PubMed ID: 6887114 [No Abstract] [Full Text] [Related]
4. New strategies for drug monitoring. Br Med J; 1977 Apr; 1(6065):861-2. PubMed ID: 851762 [No Abstract] [Full Text] [Related]
5. Post-marketing surveillance of adverse reactions to new medicines. Wilson AB Br Med J; 1977 Oct; 2(6093):1001-3. PubMed ID: 922357 [No Abstract] [Full Text] [Related]
6. Systems for evaluation of new drugs in the United Kingdom. Beard K Pharmacoepidemiol Drug Saf; 2001; 10(5):439-43. PubMed ID: 11802590 [TBL] [Abstract][Full Text] [Related]
7. Reorganization of the National Health Service: background and issues in England's quest for a comprehensive-integrated planning and delivery system. Battistella RM; Chester TE Milbank Mem Fund Q Health Soc; 1973; 51(4):489-530. PubMed ID: 4493245 [No Abstract] [Full Text] [Related]
8. A consideration of the guidelines for investigating potential new drugs in humans in the United Kingdom. McGillion FB Methods Find Exp Clin Pharmacol; 1979 Apr; 1(1):45-50. PubMed ID: 552581 [No Abstract] [Full Text] [Related]
9. Performance monitoring. New look at examining output. Talbot P Health Serv J; 1986 Sep; 96(5017):1231. PubMed ID: 10278968 [No Abstract] [Full Text] [Related]
10. Evaluating drugs: a new approach. Br Med J; 1977 Nov; 2(6098):1302. PubMed ID: 338102 [No Abstract] [Full Text] [Related]
11. Consumer participation in administration of health services. Axelrod SJ Isr J Med Sci; 1974; 10(1):32-42. PubMed ID: 4825420 [No Abstract] [Full Text] [Related]
12. Community health councils. Lancet; 1973 Feb; 1(7799):357-8. PubMed ID: 4121942 [No Abstract] [Full Text] [Related]
17. Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods. Inman WH Br Med J (Clin Res Ed); 1981 Apr; 282(6270):1131-2. PubMed ID: 6786470 [TBL] [Abstract][Full Text] [Related]
18. Effective management of health. Logan RF; Klein RE; Ashley JS Br Med J; 1971 May; 2(5760):519-21. PubMed ID: 5579500 [No Abstract] [Full Text] [Related]
19. [The "paired cards" system. A practical and generally applicable procedure for the clinical trial of drugs (author's transl)]. Schenck EG; Kirchert W Arzneimittelforschung; 1978; 28(1a):192. PubMed ID: 580218 [TBL] [Abstract][Full Text] [Related]
20. Positive reporting? Is there a bias is reporting of patient and public involvement and engagement? Chew-Graham C Health Expect; 2016 Jun; 19(3):499-500. PubMed ID: 27115321 [No Abstract] [Full Text] [Related] [Next] [New Search]